Immunovant
Price & Volume
Stats
See moreOpen | $27.57 |
Previous Close | $27.20 |
Day Range | $26.94-$27.81 |
52W Range | $12.72-$27.92 |
Market Cap | $5.4B |
Shares Short | 16M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.67 |
News
See moreYahoo Finance • 19 days ago
Immunovant Provides Corporate Updates and Reports Financial Results for the Third Quarter Ended December 31, 2025
Yahoo Finance • 2 months ago
Is Immunovant Stock a Buy After Roivant Sciences Increased Its Stake by $350 Million?
Yahoo Finance • 2 months ago
Immunovant drops 7%, prices $550M stock offering
Yahoo Finance • 3 months ago
Oppenheimer Maintains Outperform Rating on Immunovant (IMVT) Following Q2 2026 Earnings
About
CEO | Dr. Eric Venker M.D., Pharm.D. |
Address | 320 West 37th Street, New York, NY, United States, 10018 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 362 |
